RT-310 Dose Escalation BPH Study

Clinical trial NCT06136819 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06136819
Sponsor: Resurge Therapeutics Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

BPH (Benign Prostatic Hyperplasia)Lower Urinary Tract Symptoms

Start date: 2024-04-19
Primary completion: 2025-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.